Navigation Links
SynergEyes, Inc. Launches New Hybrid Lens Design for Keratoconus Patients
Date:7/20/2009

CARLSBAD, Calif., July 20 /PRNewswire/ -- SynergEyes, Inc., the high Dk hybrid contact lens manufacturer, recently introduced a new advanced lens design for keratoconus patients. ClearKone(TM) is a revolutionary contact lens that takes advantage of the best features of the hybrid platform, providing superior visual acuity, centration, stability, and all-day comfort. The patent-pending design is optimized to vault the predominant irregularities of the keratoconic cornea, thus effectively restoring vision to a vast majority of irregular cornea patients, without compromising comfort or eye health, even in the most challenging cases. ClearKone(TM) is now available in limited release in the United States, Canada and Puerto Rico.

SynergEyes lenses are the only FDA-cleared hybrid contact lenses specifically designed for keratoconus vision correction. The SynergEyes(R) KC lens was introduced in 2006, and many keratoconus patients are successfully wearing this design. However, SynergEyes(R) KC is most successful on central, nipple cones, which represent only a portion of the total number of keratoconus cases.

"SynergEyes recognized the need to develop a hybrid contact lens design that could fit a much broader spectrum of keratoconus patients, including oval cones, highly advanced central cones, decentered cones and depending on the specifics of the case, globus keratoconus and pellucid marginal degeneration," says Kellie Kaseburg, Vice President of Global Marketing for SynergEyes. "The ClearKone(TM) lens does just that and will allow many more keratoconus patients to experience the benefits of hybrid technology."

The ClearKone(TM) lens utilizes revolutionary hybrid technology to give keratoconus patients the very best technology has to offer -- the excellent visual clarity of a high-oxygen rigid gas permeable contact lens and the all-day comfort and convenience of a soft lens. What makes the C
'/>"/>

SOURCE SynergEyes, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
2. UPMC Health Plan Launches New Personal Health Record
3. HealthInsuranceFinders.com Launches Video Contest for Young Directors
4. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
5. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
6. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
7. Mannatech Launches Phase One of New Sales and Training Tools
8. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
9. Actavis Launches Carvedilol Tablets in the U.S.
10. MedQuist Re-launches New, Improved Web Site
11. Elsevier launches new journal: Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...NSAS CITY, Mo., Dec. 4 The large, ...al Association of Free Clinics (NAFC) in Kansas Ci...ick but also for anyone who is uninsured and has n... health clinic will receive preventive primary car...ious large free clinic events this fall in Houston...
(Date:12/4/2009)...ASHINGTON, Dec. 4 While... control health care costs, Leapfrog,s purchaser m...mple -- delivering the best quality care in the na...ncy. Thirty-four urban, eight children,s and three... Hospitals, based on results from The Leapfrog Hos...
(Date:12/4/2009)...ORD, Calif. A new study shows that muscle cells g... to squeeze shut properly. The work, performed in ...s with conditions such as gastric reflux and fecal...trengthen sphincters, which are the bands of muscl...nal tract. Weakness in these areas can cause gastr...
(Date:12/4/2009)...5 million Americans are recruited annually to part...ce for Human Research Protection (AHRP), and most ... Research institutions view payments to voluntee...ompensation for potential risks related to partici...that volunteers have a very different view of clin...
(Date:12/4/2009)...hether procedure done immediately or 3 weeks later...Day News) -- Timing of surgical repair or reconstr...affect patient outcome, a new study has found. ,...matic knee dislocations that can occur in high-imp...time to perform surgery to repair these injuries h...
Breaking Medicine News(10 mins):Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2
...sumption of illicit or noncommercial alcohol is wi...es significantly to the global burden of disease, ...ternational Center for Alcohol Policies (ICAP). Th...rfeit or unregistered products, in three regions: ...
...te radio,channel created for medical professionals...ewest strategic programming partnership with the A...professional association of medical,directors, att...a,great opportunity to reach a large audience abou...
...Inc., a leader,in the development of predictive dr...tional funding to expand the development and comme...ic test that helps physicians select the,most effe... Adams Capital Management, Quaker BioVentures, Bir...
...a mastectomy who undergo radiation therapy after i...reconstruction provides fewer long-term complicati...er and implant reconstruction, according to a stud...utic Radiology and Oncology., After undergoing a m...
...ay be key, study says , , THURSDAY, Nov. 2...keup of alcoholics may affect how much they drink,...brain,s control of serotonin, a mood-influencing n...hat person, said study co-author Ming D. Li, head ...
...LC today,announced the acquisition of Terrace Inte...lth, of Redlands, CA, a leading national distribut... integrative healthcare market. , The combin...tional supplements market. "This new organization ...
Other Medicine News:Health News:Report finds extensive use of illicit alcohol 2Health News:ReachMD Announces New Strategic Partnership with American Medical Directors Association 2Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 2Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 3Health News:Type of breast reconstruction impacts radiation therapy outcomes 2Health News:Genetic Trait Linked to Alcoholism 2Health News:Emerson Ecologics Announces Acquisition of TIDhealth 2Health News:Emerson Ecologics Announces Acquisition of TIDhealth 3
(Date:12/4/2009)...Newswire-FirstCall/ -- Northwest Biotherapeutics, ...: NWBO) announced today that the US Patent and Tra...n a system for automation of the initial stages of...apeutic cancer vaccines. These initial manufactur...of dendritic cells (which are the critical ingredi...
(Date:12/3/2009)...PRNewswire-FirstCall/ -- Allen Medical Systems, a ... ), today announced the launch of its new Allen Am...siness website www.AllenAmatech.com . ,, Th...dentity and includes an online version of the new ...sign specifications for the products. "We hope to ...
(Date:12/3/2009)...ec. 3 Ted Karkus, Chairm...GLY ) www.quigleyco.com announced today that the...tunities to develop prescription pharmaceutical an... best interests to focus primarily on the OTC/Pers...ot limited to its Cold-EEZE® and Kids-EEZE...
Breaking Medicine Technology:Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Many Childhood Cancer Survivors Never Marry 59131 1Many Childhood Cancer Survivors Never Marry 59131 2Swine Flu 28H1N1 29 Virus Destroyed by Innovative Air Treatment Technology 59127 1Swine Flu 28H1N1 29 Virus Destroyed by Innovative Air Treatment Technology 59127 2ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test 5321 1ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test 5321 2ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test 5321 3ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test 5321 4
...d ICAAC/IDSA meetings this week, SAN DIEGO, Oct. ...itional clinical and preclinical results with MP-3...n inhaled solution delivered by,an Investigational... (CF),and chronic obstructive pulmonary disease (C... MP-376 was well tolerated at all dose levels test...
...rst Responses in Solid Tumours Reported., Aurora ... are,implicated in both the onset and progression ... Aurora kinase inhibitors will be presented today ...I-AACR Symposium "Molecular,Targets and Cancer The...8,in Geneva. Dr Laffranchi, Director Clinical Rese...
Other Medicine Technology:Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 2Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 3Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 4Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 5Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis 6Nerviano Medical Sciences Invited by EORTC-NCI-AACR to Present the State-of-the-Art of Aurora 2Nerviano Medical Sciences Invited by EORTC-NCI-AACR to Present the State-of-the-Art of Aurora 3
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: